Garlic (Food Form) for Cancer Risk Reduction

Preliminary evidence 4 studies

Research suggests that the available studies linked here do not provide meaningful evidence specifically examining garlic in food form as a tool for cancer risk reduction. The four studies included cover topics such as genetic influences on metabolomics data, supplement use and COVID-19 infection risk, metabolic changes following weight loss in type 2 diabetes, and lifestyle changes in older adults during pandemic lockdowns — none of which directly investigate garlic consumption and cancer outcomes. The one study that does mention garlic, a large observational study of over 1.4 million app users, found no significant association between garlic supplement use and reduced infection risk, and it did not address cancer at all. Based on the studies provided, no conclusions can be drawn about garlic in food form and cancer risk reduction, and readers interested in this topic would need to consult research that directly addresses this question.

Related studies

Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.

Title Type Year Direction Match
Genome-wide Association Studies of Missing Metabolite Measures: Results From ... Other 2024 Neutral 90
Dietary supplements during the COVID-19 pandemic: insights from 1.4M users of... Other 2020 Neutral 85
The metabolomic signature of weight loss in the Diabetes Remission Clinical T... Other 2022 Neutral 80
Changes in health behaviors, mental and physical health among older adults un... Other 2021 Neutral 75

← Back to Garlic (Food Form)

Medical Disclaimer: Noyemi provides information from published research for educational purposes only. This content is not medical advice and does not replace consultation with a qualified healthcare provider. Always consult your doctor before starting, stopping, or changing any supplement regimen, especially if you take medications or have existing health conditions.